CiVi Biopharma Holdings, Inc. — Form D
CiVi Biopharma Holdings, Inc. of Chevy Chase, MD, a company, filed a Form D exempt-offering notice with the SEC on 2020-12-30. The offering totals $27.5M, of which $27.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-12-30
- Form: D
- Accession: 0001740380-20-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $27.5M
- Amount sold: $27.5M
- Investors: 9
- Date of first sale: 2020-11-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-384757
Issuer
- Name: CiVi Biopharma Holdings, Inc.
- CIK: 0001740380
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 5425 Wisconsin Ave., Chevy Chase, MD, 20815
- Phone: 301.968.2392
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Aaron Davis | Director | Miami, FL |
| Christopher Fuglesang | Director | Chevy Chase, MD |
| Shalom Jacobovitz | Director | Salt Lake City, UT |
| Carole Nuechterlein | Director | Chevy Chase, MD |
| Henrik Oerum | Director | Chevy Chase, MD |
| Shalom Jacobovitz | Executive Officer | Salt Lake City, UT |
| Matthew Pietras | Executive Officer | Huntersville, NC |
| Henrik Oerum | Executive Officer | Chevy Chase, MD |
Other filings by this issuer (1)
More